BRONX, N.Y., Feb. 12, 2017 -- New York City and Bronx area Optometrist Pelham Parkway Vision Center is pleased to announce that they will be making PROKERA® products available to their clients. Treatments with PROKERA® can bring profound relief to optometry clients who are suffering the effects of dry eye and related conditions.
PROKERA® instantly helps to reduce inflammation and accelerate the healing time for dry, inflamed eyes. It is a biologic corneal bandage device that can treat and heal eye conditions such as keratitis (dry eye), persistent epithelial defects, recurrent corneal erosions, neurotrophic corneas, filamentary keratitis, herpetic ulcers, and numerous other diseases of the ocular surface.
Dry eye refers to the inability of the eye to produce tears to help nourish and lubricate the eye. In some cases, sufficient tears are produced, but they are of poor quality, as they do not contain enough healthy oils and mucus. As a result, vision and eye health suffers. Dry eye often affects older adults and can become worse with age. Persons with the condition of dry eye often experience a gritty sensation in the eyes that can burn, feel itchy or cause general irritation. In advanced cases, the eyes can become scratched and damaged, impairing vision, eye health, and quality of life.
When treating dry eye, optometrists aim to help restore and maintain optimal amounts of moisture in the eyes to reduce discomfort and promote health. PROKERA® devices are the only products of their kind that have been cleared by the FDA as a solution for reducing inflammation and promoting the healing and regeneration of the ocular surface.
PROKERA® products promote natural, therapeutic healing with their content of amniotic membrane tissue. The PROKERA® company’s proprietary CryoTek® processing method causes natural therapeutic actions and healthy biological activity so that damaged eye surfaces can heal.
PROKERA® products can bring improved tear production, reduced inflammation and pain, less scarring, clear corneas, improved vision, and better eye health. Quality of life is improved as discomfort fades.
Optometrist Dr. Diana Ilyasova of Pelham Parkway Vision Center appreciates the PROKERA® solution due to its safety, effectiveness, and lack of risk of IOP spikes (intraocular pressure). PROKERA® can also be used in conjunction with other healing solutions such as topical agents.
Dr. Oleg Lisitsyn says, “We are pleased to offer innovative PROKERA® products in our Bronx optometry clinic. We look forward to improving the quality of life of our clients with PROKERA® products.”
Pelham Parkway Vision Center is located at 735 Lydig Avenue in Bronx, New York. Those in New York City area and surrounding communities who would like to learn more about PROKERA® treatments for dry eye or book an appointment may do so by calling (347) 897-5570. Additional information is also available on their website at http://pelhamparkwayvisioncenter.com/.
Pelham Parkway Vision Center, (347) 897-5570


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



